Health And Medicine

Managing myocardial infarction – and the resulting heart failure – remains a clinical challenge. To search for chemicals that can stimulate cardiac muscle cell production, Vanderbilt Institute of Chemical Biology investigators led by Tao Zhong, Ph.D., Terri Ni, Ph.D., and Eric Rellinger, M.D., turned to a novel drug discovery tool:… Read More

Images of individuals with Alagille syndrome (National Institutes of Health) Mutations in the Jagged1 gene cause Alagille syndrome, an inherited disorder that affects the liver, heart, kidneys and facial structure. Patients with Alagille syndrome often have a prominent forehead, a flattened midface and a prominent chin; some have a cleft… Read More

Mary Gwyn Bowen, R.N., is studying whether art on the walls motivates patients to ambulate more quickly following cardiac surgery. (Joe Howell / Vanderbilt) Following cardiac surgery, patients are encouraged to get out of bed and walk as soon as possible, a daunting task to many who… Read More

A Vanderbilt-led workshop for military health care providers could lead to more post-deployment mental health referrals. Read More

Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study released online by The Journal of Infectious Diseases. Read More

Ela Knapik, associate professor of medicine, and colleagues are using zebrafish to explore the molecular and cellular mechanisms that cause birth defects of the face and skeleton. Read More

(Benedict Campbell/Wellcome Images) Mitosis, or the separation of chromosomes during cell division, is driven by dynamic interactions between the kinetochore region on chromosomes and string-like structures called microtubules. A number of proteins, including the enzyme Cdk1, regulate these interactions, but it is unclear what kinetochore components such enzymes work… Read More

The Bill and Melinda Gates Foundation has given them $1 million to three Vanderbilt scientists to develop a point-of-care sample collection and preparation product that could bring advanced medical diagnostic testing to the third world. Read More

The progression of new drug candidates for schizophrenia with partner Janssen Pharmaceutica is the latest evidence that a new collaborative model for drug discovery pioneered at Vanderbilt may help identify and develop innovative candidate drugs for treatment of major brain disorders. Read More

Young bone marrow cells alleviate aging-related kidney changes in mice. Read More

Protein helps ensure proper division of chromosomes during cell division. Read More

Host cell protein may be a target for strategies to limit spread of virus-induced squamous cell cancers. Read More

Children of childhood cancer survivors who were treated with radiation or some forms of do not have an increased risk for birth defects compared to children of cancer survivors who did not receive such treatments. Read More

Jeffrey Sosman (Vanderbilt) Jeffrey Sosman, professor of medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of cancer investigators supported by Stand Up To Cancer (SU2C) and the Melanoma Research Alliance. Sosman is among the Dream Team’s principal investigators who… Read More

Twenty-five years after he received the Nobel Prize, Stanley Cohen’s discovery of epidermal growth factor continues to transform medicine. Read More

Members of informatics team have been recognized by National Library of Medicine for gene app. Read More

Research led by Timothy Sterling, professor of medicine, has led to an important change in The Centers for Disease Control and Prevention's recommendations in the regimen for prevention of the centuries-old scourge, tuberculosis. Read More

Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis. Read More

Even when lung operations for suspected cancer resection results in a benign diagnosis, there still may be significant benefits to the procedure, new research suggests. Read More

Individuals with atrial fibrillation who have a particular genetic variant respond better to rate control therapy. Read More